Voinosis
1 known investors
Voinosis develops acoustic biomarker and multimodal AI technology (combining voice and eye-tracking) for early screening and monitoring of brain health, targeting neurological and auditory conditions. The company works with medical and research institutions to validate its clinical AI for use in both clinical and everyday settings.
Founders & leadership
μ
μ μ μCEO
Investors Β· 1
Frequently asked questions
- What does Voinosis do?
- Voinosis develops acoustic biomarker and multimodal AI technology (combining voice and eye-tracking) for early screening and monitoring of brain health, targeting neurological and auditory conditions. The company works with medical and research institutions to validate its clinical AI for use in both clinical and everyday settings.
- Who are Voinosis's investors?
- Voinosis's investors include Asia2G Capital.